Lewin & Gavino Inc. – Trademark Portfolio

Entity Type: 03

Lewin & Gavino Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered and 2 are pending. Notable registered marks include MTP-CMTA. The owner is based in Temecula, CA.

P.O. Box 890249

Temecula, CA 92589

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lewin & Gavino Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Lewin & Gavino Inc. have?

Lewin & Gavino Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 pending.

What trademark classes does Lewin & Gavino Inc. file in?

Lewin & Gavino Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What are Lewin & Gavino Inc.'s most well-known trademarks?

Lewin & Gavino Inc.'s registered trademark portfolio includes well-known marks such as MTP-CMTA. These are among 1 currently registered trademark in the portfolio.

What is Lewin & Gavino Inc.'s trademark registration success rate?

Lewin & Gavino Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 2 applications are pending review.